- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
New CFOs for Cipher and Nuvo
September 6, 2016
Cipher Pharmaceuticals Inc. (Mississauga, ON) announced that Stephen L. Lemieux has been appointed Chief Financial Officer and Secretary of the company, effective September 12, 2016. Lemieux replaces Norman Evans, who is retiring after almost 10 years as Cipher's CFO. Lemieux most recently served as Vice President and CFO of Nuvo Pharmaceuticals (Mississauga). Nuvo has since filled Lemieux's role with the appointment of Mary-Jane Burkett, the company's corporate controller since 2012.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.
